Doctors’ views on fatty liver: a survey reveals gaps in fibrosis testing
NCT ID NCT07682363
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study surveys physicians in China to understand how they diagnose and manage metabolic dysfunction-associated steatotic liver disease (MASLD), a common fatty liver condition. It focuses on whether and how doctors assess liver fibrosis, a key indicator of disease severity. The goal is to identify barriers to proper evaluation and improve care for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
This study could reveal gaps in how liver fibrosis is assessed in MASLD patients, guiding better training and care standards.
What could go wrong
As a survey, it captures opinions and self-reported practices, not patient outcomes. Results may not reflect actual clinical behavior or apply outside China.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Probiotic Lysate for MASLD Trial (NCT06352697)
- Cardiovascular, Kidney & Metabolic Disease Study NCT07673822
- Time-Restricted Eating for Liver Cancer Study (NCT06824974)
- Zonulin & LBP in UC and Liver Disease – NCT07662902
- Exercise Before Liver Transplant: NCT02567591
- LiverSeek: Automated Liver Fibrosis Screening in NCT07658755
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Novo Nordisk Investigational site
RECRUITINGBeijing, China